Structural Heart Market Grow At + 10.5% CAGR Up To 2025 With Key Companies Abbott Medtronic, Boston Scientific Corporation, CryoLife, LivaNova, Lepu Medical, Braile Biomedica

The global structural heart market is diverged and estimated to mature at a rapid pace over the projected time frame. The growing internet saturation and widespread adoption of social media structures have nurtured the marketplace surge. In addition, the presence of outstanding content marketing agencies has additionally propelled the marketplace growth.

According to a new market research study titled ‘Structural Heart Market to 2025 - Global Analysis and Forecasts by Product, Procedure and End User, the global structural heart market was valued at US$ 6,406.3 Mn in 2017 and is estimated to reach US$ 13,850.2Mn by 2025. The report highlights the trends prevalent in the global structural heart market and the factors driving the market along with the restraints that are impacting its growth.

For In-Depth Review | Get Sample Copy@ https://www.theinsightpartners.com/sample/TIPHE100001164/?opsp

Top Key Players:

• Abbott
• Medtronic
• Boston Scientific Corporation
• CryoLife, Inc
• Edward Lifesciences Corporation
• LivaNova Plc
• Lepu Medical
• Braile Biomedica
• Labcor Laboratories Ltda
• Aran Biomedical Teoranta

The product segment is divided into occluders, annuloplasty rings, heart valve balloon and others. Among the product segment the occluders holds the largest market share whereas, the heart valve balloons is the fastest growing segment. The dominancy is expected to be continued by the occluders due to the advantages offered such as it reduces 50% of the meshwork material on the left atrial side and eliminates the left atrial disc microsrew it minimizes the risk of thrombus formation and damage to the distal wall of the left atrium during the implantation procedure. Also the delivery cable mechanism varies and it allows pivoting of the devices, it also have features fir the large defects and borderline length. Moreover, the devices are fully repositionable and recapturable. The market for structural heart by the product segment is expected to reach US$ 13,850.2 million by 2025 in the forecasted period. Occluders segment has the highest market share in 2017, contributing a market share of 42.0% and is expected to retain its dominance during the forecast period from 2018 to 2025 to account for a market share of 42.5% of the overall revenue generated in 2025.

Strategic Insights:-

Acquisitions and expansions were observed as the most adopted strategy in global structural heart industry. Few of the acquisitions and expansions made by the players in the market are listed below:

2018: In July, 2018, Boston Scientific Corporation announced signing of agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel Cerebral Embolic Protection System.

2017: In November, 2017, Edwards Lifesciences Corporation, announced it expansion, the expansion was done in the Costa Rica a new manufacturing plant was started.

Want To Know More | Inquiry Here @ https://www.theinsightpartners.com/inquiry/TIPHE100001164/?opsp

Innovative Structural Heart Services:-

The rise in technological advancement has led to various innovations for the products and treatment services that enables the surgeon, physicians and other healthcare providers to provide best health to their patients. The innovations are not only limited to the healthcare facilities nevertheless they are extended to the programs that are being designed for the patients to get benefit out of the treatment facilities. Food and Drug Administration (FDA) has approved various therapies that are limited to the selected groups of the patients. There some personal healthcare provider who analyze the heart condition and available treatment of choices. For instance, Premier Health is among those providers who provides innovative structural heart services which include alcohol septal ablation which treats hypertrophic cardiomyopathy with the use of catheter-based technology, balloon valvuloplasty which uses a transcatheter approach for widening up a stiff and narrow heart valves, atrial septal defect transcatheter repair which closes an opening between the heart’s left and right atrium without surgery and such more services are being provided by the service providers.

Rise in the Number of Cardiovascular Procedure and Corresponding Training Programs:-

The cardiac arrest or the other heart related diseases are wide spreading incidence and are impacting severely on the public health and wellbeing. The cardiovascular disease are the second leading cause of death across the world. For instance, according to World Health Organization (WHO) approximately 17.7 million people died in 2015 due to the cardiovascular diseases, the number contributes to the 31% of the global deaths. The among these deaths it was estimated that near about 7.4 million deaths were due to coronary heart diseases and near about 6.7 million deaths were due to the heart stroke. Among the 17 million deaths the premature deaths were contributed due to non-communicable diseases in 2015, this number relates approximately to 82% were in low and middle-income countries, and approximately 37% were due to CVDs. Therefore, various strategies and initiations are being taken to control the cardiovascular diseases.

Product Insights:-

The global structural heart market by product was led by occluders segment. In 2017, the occluders segment held a largest market share of 42.0% of the structural heart market, by product. The segment is also expected to dominate the market during the year 2025, due to benefits such as, 50% of reduction in the meshwork material on the left atrial side and eliminates the left atrial disc microsrew, minimizes the risk of thrombus formation and damage to the distal wall of the left atrium during the implantation procedure

Procedure Insights:-

The structural heart market by procedure was segmented into surgical aortic valve replacement, transcatheter aortic valve replacement, mitral repair and left atrial appendage closure. The surgical aortic valve replacement segment held the largest share of the market, by procedure. The segment is also likely to dominate during the forecast period, as it helps in restoring the normal blood flow, prolong life and help to preserve the function of heart muscles.

End User Insights:-

The structural heart market by end user was segmented into hospital, ambulatory surgical centers and cardiac centers. The hospitals segment held the largest share of the market, by end user. The segment held a market share of around 49.9% during the year 2017 and is anticipated to dominate by 2025, among the end users.

By Product
• Occluders
• Annuloplasty Rings
• Heart Valve Balloons
• Others

By Procedure
• Surgical Aortic Valve Replacement
• Transcatheter Aortic Valve Replacement
• Mitral Repair
• Left Atrial Appendage Closure

By End User
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers

By Geography
• North America
• Europe
• Asia Pacific (APAC)
• Middle East & Africa (MEA)
• South America (SAM)

Get Customization On Discount@ https://www.theinsightpartners.com/discount/TIPHE100001164/?opsp

Contact us:

The Insight partners,

Phone: +1-646-491-9876

Email: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

This release was published on openPR.